Видео ютуба по тегу Speaker: Charles Craddock

Charles Craddock CBE | LATSS 2024 talk
Charles Craddock CBE | LATSS 2024 talk
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock on the latest UK AML trials
Charles Craddock on the latest UK AML trials
Using targeted therapies to optimize transplant outcomes in AML
Using targeted therapies to optimize transplant outcomes in AML
Managing post-transplant relapse in AML
Managing post-transplant relapse in AML
Ask the Expert: Charles Craddock answers your transplantation questions at iwAL 2025
Ask the Expert: Charles Craddock answers your transplantation questions at iwAL 2025
AlloSCT in older, fit patients with AML: understanding predictors of post-transplant toxicity
AlloSCT in older, fit patients with AML: understanding predictors of post-transplant toxicity
The IMPACT Trials Network for improving outcomes for stem cell transplant patients
The IMPACT Trials Network for improving outcomes for stem cell transplant patients
Novel transplant strategies in AML and the importance of reducing the risk of relapse in patients
Novel transplant strategies in AML and the importance of reducing the risk of relapse in patients
Accelerating assessment of therapies in hematology
Accelerating assessment of therapies in hematology
Personalized treatments to manage post-transplantation outcomes in AML: insights from MORPHO
Personalized treatments to manage post-transplantation outcomes in AML: insights from MORPHO
Challenges in HSCT clinical trials in Europe
Challenges in HSCT clinical trials in Europe
Charles Craddock's ASH 2019 transplant highlights
Charles Craddock's ASH 2019 transplant highlights
The COSI trial: addition of thiotepa to improve outcomes in patients with AML undergoing alloSCT
The COSI trial: addition of thiotepa to improve outcomes in patients with AML undergoing alloSCT
British Society for Haematology: driving a therapeutic revolution in hematology
British Society for Haematology: driving a therapeutic revolution in hematology
UK transplantation trials network: four IMPACT trials launching in 2018
UK transplantation trials network: four IMPACT trials launching in 2018
Know AML webinar | What are mutations, and why do they matter in AML?
Know AML webinar | What are mutations, and why do they matter in AML?
Understanding the biology behind AML relapse
Understanding the biology behind AML relapse
The role of Cure Leukemia in improving access to clinical trials for patients
The role of Cure Leukemia in improving access to clinical trials for patients
Know AML webinar | Closing remarks and Q&A
Know AML webinar | Closing remarks and Q&A